Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateResults22h ago

Birla Corporation Ltd

Intimation of Investor/Analyst Conference Call on the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 scheduled to be on held on 25th July, 2026.

Birla Corporation Ltd has scheduled an investor/analyst conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026. The call is set to be held on Saturday, 25th July, 2026 at 3:30 P.M. (IST).

Read more →📎 1 attachment
BSEBoard MeetingResults22h ago

UCO Bank

Outcome of Board Meeting - Approval of Unaudited Financial Results of the Bank for the quarter ended 30.06.2026 with Limited Review

UCO Bank's board of directors has approved the unaudited financial results for the quarter ended 30th June 2026, with a net profit of ₹2,80,954. The bank's total income for the quarter was ₹4,64,224, with interest earned of ₹6,99,600 and interest on balances with RBI & other inter-bank funds of ₹21,331. The bank's net worth is ₹1,15,348, and the total debt to total assets ratio is 0.06.

Read more →📎 1 attachment
BSEResultResults22h ago

Dr Reddys Laboratories Ltd

Unaudited Financial results for the quarter ended June 30, 2026

Dr. Reddy's Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenues of Rs. 80,705 million, gross profit of Rs. 37,540 million, and a net profit of Rs. 4,348 million. The company has also announced the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, and the appointment of M/s Deloitte Haskins & Sells, LLP as the Independent Registered Public Accounting Firm.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults22h ago

Indusind Bank Ltd

Press Release : Q1 FY 26-27

Indusind Bank Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, with net interest income at ₹4,685 crores, net profit at ₹1,037 crores, and a net worth of ₹64,798 crores.

Read more →📎 1 attachment
BSECompany UpdateResults22h ago

PFL Infotech Ltd

Statement of Deviation & Variation

PFL Infotech Ltd has intimated that the Statement of Deviation or Variation under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable for the quarter ended on 30th June 2026, as there was no public issue, rights issue, or preferential issue during the quarter.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults22h ago

Indusind Bank Ltd

Please find attached Investor Presentation for quarter June 30, 2026

IndusInd Bank Ltd has released its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, showing a 1% YoY increase in net interest income and an 8% YoY growth in operating profit. The bank's net profit grew 72% YoY and 75% QoQ to ₹1,037crs. The bank's asset quality continued to improve with GNPA at 3.25% and NPA at 0.95%. The bank's CRAR stood at 17.15% and PCR at 71%. The bank's key financial metrics showed a 3% YoY increase in loans and a 4% QoQ increase in deposits.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults22h ago

Jio Financial Services Ltd

Transcript of Presentation on the unaudited financial results (Consolidated and Standalone) for the quarter ended June 30, 2026

Jio Financial Services Ltd reported strong Q1 FY27 earnings, with Consolidated Total Income growing 141% YoY to ₹1,496 crores, and Profit Before Tax excluding dividend and exceptional item expanding 18% YoY to ₹461 crores. The company's lending business, Jio Credit, saw its Gross AUM surge 2.6x year-on-year to ₹30,667 crores, while Jio Payments Bank deposits grew 1.7x to ₹617 crores. The company's insurance premiums facilitated reached ₹238 crores, and JioBlackRock AMC scaled its closing AUM to ₹18,412 crores.

Read more →📎 1 attachment
BSEBoard MeetingResults22h ago

Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the unaudited Financial ....

Jagsonpal Pharmaceuticals Ltd has scheduled a board meeting on July 29, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and has closed the trading window till July 31, 2026.

Read more →📎 1 attachment
BSEAGM/EGMResults22h ago

India Glycols Ltd

Please find attached

India Glycols Ltd has announced the 42nd Annual General Meeting (AGM) to be held on August 19, 2026, through video conferencing. The meeting will be held in compliance with the Companies Act, 2013, and relevant circulars issued by the Ministry of Corporate Affairs. The notice and annual report for the financial year 2025-26 will be sent to shareholders via email and made available on the company's website.

Read more →📎 1 attachment
BSEBoard MeetingResults22h ago

Indusind Bank Ltd

Outcome of Board Meeting

Indusind Bank Ltd announced the outcome of its board meeting, approving unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, along with a limited review report. The board also approved convening of the 32nd Annual General Meeting on August 27, 2026, and plans to raise funds through debt securities and equity instruments.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults22h ago

Dr Reddys Laboratories Ltd

Outcome of Board Meeting held on July 22, 2026

Dr Reddy's Laboratories Ltd announced unaudited financial results for the quarter ended June 30, 2026, with revenues of Rs 80,705 million, gross profit of Rs 37,540 million, and profit for the period of Rs 4,348 million. The company also announced the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, and the appointment of M/s Deloitte Haskins & Sells, LLP as Independent Registered Public Accounting Firm.

Read more →📎 1 attachment